H Y Zhuo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

H Y Zhuo

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Zhonghua Nei Ke Za Zhi|December 1, 1986

[Nephrotic syndrome and hypercoagulable state]X J Zhou, H Y Zhuo, Y Q Liu

Medical Oncology (Northwood, London, England)|January 10, 2015

Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphomaY Q Wang, Y Yang, H Y Zhuo, et al.

Pageof 1

Search research articles

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Zhonghua Nei Ke Za Zhi|December 1, 1986

[Nephrotic syndrome and hypercoagulable state]X J Zhou, H Y Zhuo, Y Q Liu

Medical Oncology (Northwood, London, England)|January 10, 2015

Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphomaY Q Wang, Y Yang, H Y Zhuo, et al.

Pageof 1